Jeff Golfman, founder and president of Send 123, in a conversation with Pharmaceutical Executive, discusses how rising geopolitical tensions around Iran and broader global disruptions are reshaping pharmaceutical and medical supply chains.
Jeff Golfman
Advertisement
Jeff Golfman is the Founder & President of Send 123, an AI-powered smart procurement platform for businesses. With several decades of experience at the intersection of global sourcing, manufacturing and logistics, Jeff builds businesses that solve complex systemic problems through innovation and transparency.
Articles by Jeff Golfman
In the final part of his interview, Jeff Golfman discusses how data-driven supply chain mapping and collaborative procurement models can gain traction as companies move beyond cost-focused sourcing to strengthen resilience.
In the second part of his interview, Jeff Golfman notes how shelf-life constraints and shipping delays heighten drug shortage risk, prompting calls for diversified sourcing and larger inventory buffers.
In the first part of his interview, Jeff Golfman, notes how The Strait of Hormuz disruption exposes broader global supply chain contraction, raising risks for vaccines, cancer therapies, and other critical medicines.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote
2
Global Disruptions to the Pharma Supply Chain: Q&A with Jeff Golfman
3
FDA Approves Auvelity for Treatment of Agitation Associated with Dementia Due to Alzheimers
4
Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?
5